Xi'an Epanggong Pharmaceutical

Xi'an Epanggong Pharmaceutical is a modernized Chinese pharmaceutical company specializing in the research, development, production, and marketing of traditional Chinese patent medicines (Zhongchengyao). Established in 2003 through the restructuring of the historic Xi'an Traditional Chinese Medicine Factory (founded in 1966), the company operates across OTC and prescription drug sectors. Its core product portfolio includes Guchang Zhixie Pills (for colitis and diarrhea), Yixin Chushi Zhitong Capsules (for joint pain and rheumatism), and other formulations targeting cardiovascular, respiratory, and pediatric conditions. The company is listed on China's National Equities Exchange and Quotations (NEEQ) under the stock code 835912.